News

06.05.2019

“Here at Bell, we combine handcraft and automation”

“Here at Bell, we combine handcraft and automation”

Over the space of 150 years, a butcher’s in Basel has grown into an international food company, with the Bell Food Group now employing more than 12,000 people in 15 countries. Markus Ettlin, Head of Industry 4.0/Automation at the Bell Food Group, provides an update on the company’s current Industry 4.0 projects, the limits of automation, and innovations in the food sector.

mehr >
23.05.2019

Santhera receiving up to 105 million Swiss francs

Santhera receiving up to 105 million Swiss francs

Pharmaceutical company Santhera has entered into a license agreement with the Chiesi Group. This will license the Santhera drug Raxone. Santhera is also conducting research in the field of gene therapy together with the Biozentrum of the University of Basel.

mehr >
21.05.2019

BaseLaunch is top European accelerator

BaseLaunch is top European accelerator

Healthcare Accelerator BaseLaunch, which is operated by the location promotion organization BaselArea.swiss, is among the leading accelerators of its kind in Europe, according to a media report. BaseLaunch is the only Swiss Healthcare Accelerator to feature.

mehr >
02.04.2019

“The Basel region is very advanced in healthcare innovation”

“The Basel region is very advanced in healthcare innovation”

A new master’s degree at the FHNW University of Applied Sciences and Arts Northwestern Switzerland aims to prepare the next generation of professionals in the life sciences industries: Students in “Medical Informatics” are trained to apply the latest technologies during projects for the medical and pharmaceutical industries. Professor Enkelejda Miho from the Institute for Medical and Analytical Technologies at FHNW is confident that the combination of life sciences, informatics and business brings forward a desired new profile of professionals.

mehr >
21.05.2019

Wie sicher ist Ihr IT-System?

Wie sicher ist Ihr IT-System?

Am Technology Circle im Business Park Oberbaselbiet in Zwingen wurde einmal mehr deutlich, welche zentrale Rolle das Thema Cybersecurity in den Bereichen Betriebstechnologie (OT) und Informationstechnologie (IT) in der digitalisierten Industrie spielt. Am Technology Circle sollte aufgezeigt werden, mit welchen Bedrohungsszenarien zu rechnen ist und wie Unternehmen vorkehren können. BaselArea.swiss hatte die beiden ausgewiesenen Experten für Cybersecurity, Patrick Hofer von der Firma Axians und Philippe Kapfer von NextDay.vision eingeladen, ihr Wissen mit den interessierten Teilnehmer auszutauschen.

mehr >
20.05.2019

Green light for tax proposal

Green light for tax proposal

Swiss voters paved the way for a reform of corporate taxes on Sunday. This means the tax cuts that were enforced in Basel-Stadt retroactively as per 1 January are confirmed.

mehr >
28.03.2019

33 recently arrived companies create hundreds of jobs

Basel and the Rhine - attractive for companies (img: Basel Tourismus)

The efforts of BaselArea.swiss proved extremely successful in 2018. 33 companies – seven more than in the previous year – were persuaded to move to the Basel economic region. 16 companies arrived from Europe, nine of which came from Germany. BaselArea.swiss also supported six Swiss companies in the search for a suitable business location in the Basel region. Of the newly arrived companies, 19 operate in the life sciences and chemicals sectors.

mehr >
16.05.2019

Salina Raurica is making good headway

Salina Raurica is making good headway

The area of Salina Raurica East is to be developed into a strong research, commercial and residential center in the next few years. A jury has selected a proposal for the urban development of the district and construction work is due to start in 2023.

mehr >
16.05.2019

Impact Hub Switzerland etabliert grösste Community für Entrepreneure in der Schweiz

Impact Hub Switzerland etabliert grösste<br/>Community für Entrepreneure in der Schweiz

Das globale Impact Hub Netzwerk umfasst rund 100 Coworking Spaces für UnternehmerInnen in mehr als 50 Ländern. In der Schweiz entstanden seit 2011 Impact Hubs in Zürich, Genf, Bern, Lausanne und Basel. Mit der neu gegründeten Dachorganisation „Impact Hub Switzerland“ werden nun die Aktivitäten aller fünf Hubs gebündelt. Rund 2'000 Mitglieder bilden das größte Netzwerk von Entrepreneuren, Kreativen und Techies in der Schweiz. Im Fokus des Impact Hubs Switzerland stehen sowohl Unternehmertum für eine nachhaltige Entwicklung als auch eine schweizweit vernetzte Community sowie nationale Veranstaltungen und Förderprogramme.

mehr >
05.03.2019

Healthcare innovations gain traction with the DayOne Accelerator

Healthcare innovations gain traction with the DayOne Accelerator

Three innovative healthcare startups participate in the first round of the DayOne Accelerator. Faraz Oloumi from Aurteen, Chang Yun from Noul and Christian Vogler and Leo Gschwind from Advancience are examples of how far conviction can get you.

mehr >
14.05.2019

University of Basel amongst the most innovative in Europe

University of Basel amongst the most innovative in Europe

Thomson Reuters has published its annual report on Europe’s Most Innovative Universities. Switzerland has four in the top 20. The University of Basel is among them.

mehr >
13.05.2019

Tackling the healthcare innovation chasm

From the left side: Paul Kohlhaas, Linumlabs (Molecule), Giovanni Nisato (Health Hacking Lab), Melissa Penny (Swiss TPH), Martin Etzrodt (Akasha Foundation), Peter Groenen (Idorsia), Noé Brasier (University Hospital Basel), Thomas Brenzikofer (DayOne/ BaselArea.swiss)

Presentation by Melissa Penny, Swiss TPH - The global health perspective (innovation for neglected diseases)

Presentation by Noé Brasier, University Hospital Basel - Presentation by Innovation at the hospital – The USB way to do it

Presentation slides by Peter Groenen, Idorsia

Presentation by Paul Kohlhaas, Linumlabs, Founder of Molecule - The next evolution of drug development

Presentation by Giovanni Nisato, Health Hacking Lab

The diagnosis couldn’t be worse. Healthcare innovation as we know it is stagnating and there is no cure in sight. Is that really the case? The future of healthcare innovation was the central topic at the DayOne Experts Event on May 7 in Basel. Peter Groenen, long standing industry expert, head of Translational Science at Idorsia and founding member of the DayOne Initiative, set out the facts and figures: the percentage of drug approvals is stagnating at best (except for orphan indications), the numbers of drugs brought to the patients per billion dollars spent are in stark decline, and return on investment is projected to hit the zero mark in 2020. Even when these doom figures may not become reality in the next 10 years, pharmaceutical innovation and change of the business model is required.

mehr >
05.02.2019

“We are a small company with a big portfolio”

“We are a small company with a big portfolio”

After Martine and Jean-Paul Clozel created Actelion with two other founders and grew Actelion into Europe’s biggest biotech, the company and its late-stage pipeline were acquired by Johnson&Johnson in 2017. With Actelion’s discovery- and early-stage R&D assets, the couple formed Idorsia, with the vision to build one of Europe’s leading biopharmaceutical companies

mehr >
09.05.2019

Pfizer acquires Basel-based Therachon

Pfizer acquires Basel-based Therachon

U.S. pharmaceutical company Pfizer is acquiring Basel biotech Therachon for US$ 340 million. Additional payments of US$ 470 million may also be received on the achievement of key milestones. Therachon has developed a drug for the treatment of a form of short-limbed dwarfism.

mehr >
08.05.2019

Swiss biotech industry growing

Swiss biotech industry growing

Switzerland’s biotech industry achieved growth in 2018, the Swiss Biotech Report from EY has found. The initial public offering of Basel-based company Polyphor greatly boosted capital investment in the sector. The report highlights Roivant Sciences with headquarters in Basel as a success story.

mehr >
08.01.2019

"It doesn't always have to stay the same"

Désirée Mettraux has been the CEO of Creadi since 2016. The Pax spin-off has developed the Simpego online insurance platform. The insurance expert is confident that the industry will profit if it opens itself up to partners. The aim is to make insurance fun.

mehr >
06.05.2019

EuroAirport – connecting Switzerland to the world

EuroAirport – connecting Switzerland to the world

Located at the borders of Switzerland, France and Germany, Basel-Mulhouse airport is serving the cross-border market for over 70 years. In order to underline its cross-border mission the airport positions itself under the trademark EuroAirport Basel-Mulhouse-Freiburg.

mehr >
06.05.2019

Switzerland excels with biotech start-ups

Switzerland excels with biotech start-ups

According to an article in the journal “Nature”, Switzerland is the European leader with its biotech start-up ecosystem. Based on population size, Switzerland ranks in first place for both venture capital and patent and research output.

mehr >
03.12.2018

“Momentum for blockchain in healthcare is growing in Basel”

“Momentum for blockchain in healthcare is growing in Basel”

Marco Cuomo and Daniel Fritz from Novartis got engaged in blockchain two years ago. Today, their aim is set high: With other pharma companies under the Innovative Medicines Initiative, they formed a “Blockchain Enabled Healthcare” program, due to kick off in 2019. The program that they presented at the Blockchain Leadership Summit in Basel – Switzerland’s largest conference in this field - wants no less than to define how blockchain is applied in healthcare.

mehr >
03.05.2019

Basel economy performing strongly

Basel economy performing strongly

The Basel Chamber of Commerce has conducted its spring survey for 2019. The responses have revealed that the Basel economy is currently in great shape. Companies are expecting this to remain the case, despite the expectation of a slight economic cooling.

mehr >
03.05.2019

Découvrez DMI Technologies de Delémont

Découvrez DMI Technologies, une jeune société innovante jurassienne située à Delémont. DMI Technologies est spécialisée dans les technologies MIM et CIM, c’est-à-dire la production de pièces par injection de poudres métalliques et céramiques. L’entreprise a la particularité de concevoir également les moules nécessaires à l’injection des pièces, qui sont ensuite traitées dans les fours thermiques.

mehr >
23.11.2018

Expats like Basel best

Expats like Basel best

Expats find Basel to be the best city in Switzerland, according to a study published by InterNations. Six Swiss cities were analyzed as part of its latest Expat City Ranking.

mehr >
30.04.2019

Welcome to the Basel region: Cerdia

Welcome to the Basel region: Cerdia

Cerdia’s history starts with Rhodia Acetow more than 100 years ago: The company was founded in 1912 in the Rhone valley in France. Its specialty were polyester and nylon textiles. Later, Rhodia Acetow developed huge business opportunities in producing cigarette filter tow and cellulose acetate. In 2018, the company opened a new chapter in their books: The international headquarters were moved from Freiburg i.B., Germany to Basel. The new stand-alone entity in Basel was rebranded Cerdia in March 2019. Today, Cerdia has an annual turnover of more than 600 million Swiss francs. 1300 employees work for the company with hubs in France, Singapore, the US, Brazil and Russia.

mehr >
30.04.2019

Alentis raises 12.5 million Swiss francs

Thomas Baumert of Alentis

The Basel-based biotech company Alentis Therapeutics AG has successfully concluded a CHF 12.5 million Series A financing co-lead by BioMedPartners and BB Pureos Bioventures and joined by BPI France, Schröder Adveq and the HTGF. Alentis develops therapeutics in advanced liver disease and cancer.

mehr >
14.11.2018

Roivant raised USD 200 million, now valued at USD 7 billion

Roivant raised USD 200 million, now valued at USD 7 billion

The Basel-based pharmaceutical company Roivant Sciences has raised USD 200 million in a funding round. As a result, the company is now valued at an estimated USD 7 billion.

mehr >
29.04.2019

Fully equipped lab spaces at the Switzerland Innovation Park Basel Area

Fully equipped lab spaces at the Switzerland Innovation Park Basel Area

Launching a biotech is a daunting endeavor. Resources – both human and capital - are scarce and have to be fully dedicated to advancing science and building the company. Unfortunately, a significant amount of the initial capital, time and energy are often spent on setting up lab infrastructure:  This includes negotiations with suppliers, wait times of months until equipment arrives, getting all the necessary permits, taking on the financial risk of signing long-term lease agreements, and much more.

mehr >
29.04.2019

Basel scientist speeds up search for active substances

Basel scientist speeds up search for active substances

Steven Schmitt from the Department of Biosystems Science and Engineering at ETH Zurich in Basel has developed a method with which producers of active substances can be analyzed in a much shorter time than was previously possible, enabling new antibiotic candidates to be discovered.

mehr >
05.11.2018

Three entrepreneurs, three visions of Industry 4.0

Dominik Trost (holo|one), Philippe Kapfer (NextDay.Vision), Roy Chikballapur (MachIQ)

BaselArea.swiss invited startups and Industry 4.0 projects to participate in the first Industry 4.0 Challenge. A jury from the industry chose three finalists: Philippe Kapfer with NextDay.Vision, Roy Chikballapur with MachIQ and Dominik Trost with holo|one. Learn more about their contributions and visions in the interview. You can meet the entrepreneurs at the Salon Industries du Futur Mulhouse on 20 and 21 November 2018.

mehr >
26.04.2019

Genedata wins award

Genedata wins award

The Basel-based software company Genedata has won the Best of Show Award at the Bio-IT World Conference & Expo for a software solution which speeds up comprehensive analysis processes at biopharmaceutical firms.

mehr >
24.04.2019

Virtual reality provides insight into human body

Virtual reality provides insight into human body

In a new exhibition the Department of Biomedical Engineering (DBE), a joint venture of the University of Basel and the University Hospital Basel, shows the inner workings of the human body using visualization techniques developed for practising surgeons.

mehr >
27.09.2018

"I Was Always One of Few Women in the Industry"

SOLO Swiss in Porrentruy in the canton of Jura has been making industrial furnaces for heat-treating metals since 1924. The family company with a global presence is developing against the backdrop of Industry 4.0 and is struggling to find the qualified workforce which is indispensable for what it does amid the effects of the strong franc and what are sometimes restrictive administrative regulations. Interview with Anne-Sophie Spérison, President and CEO.

mehr >
18.04.2019

Basel’s Lyfegen closes seed financing round

Basel’s Lyfegen closes seed financing round

Lyfegen, an IT company specializing in healthcare from Basel, has raised 750,000 Swiss francs in a seed financing round. The startup has developed a software solution to overcome technical hurdles in value-based healthcare.

mehr >
16.04.2019

Basel researchers develop innovative cell computer

Basel researchers develop innovative cell computer

Controlling gene expression through gene switches has long been one of the primary objectives of synthetic biology. Researchers in Basel have now developed a cell computer with two core processors.

mehr >
04.09.2018

“Our business is the most beautiful business in the world”

“Our business is the most beautiful business in the world”

Giacomo di Nepi has a successful history: A high level executive in big corporations, he transitioned towards biotech, currently as CEO of Polyphor, which, in May 2018, he led to the IPO. We spoke to Giacomo about serving patients, the timing for an IPO and the people needed in a biotech.

mehr >
12.04.2019

Approval range of Polyphor antibiotic to be expanded

Headquarter of Polyphor in Allschwil

The Allschwil-based pharma company Polyphor has developed an innovative antibiotic in the form of murepavadin. The US authorization authority has now extended the approval range of this drug by four new indications.

mehr >
11.04.2019

How Accenture hacked a hospital

How Accenture hacked a hospital

«The question is not: Will we be hacked but rather: when will we be hacked?» Under that premise, Boris Bogdan, Managing Director of Accenture in Basel, welcomed the audience to the Accenture Business Lounge on April 11 at Halle 7. The business event, organized by Accenture and BaselArea.swiss, was dedicated to the “Cyber threat landscape”.

mehr >
15.07.2018

Basel pharma companies invest most in R&D

Basel pharma companies invest most in R&D

The 24 Interpharma companies spent a total of 96 billion Swiss francs on research and development worldwide in 2017. Of this, 7 billion francs were invested in Switzerland. When compared with the sales they generated in Switzerland, the companies’ Swiss research investment was more than twice as high. According to the association, this is a testament to the great significance of Switzerland as a research location and the innovation taking place at these companies.

mehr >
11.04.2019

Smart City Lab Basel opens

Smart City Lab Basel opens

The canton of Basel-Stadt and Swiss railway company SBB have opened the Smart City Lab Basel on the Wolf Areal. Here, innovative solutions for the city of tomorrow will be born, boosting the competitiveness of the Switzerland as a whole.

mehr >
09.04.2019

Mirum Pharmaceuticals makes an entrance to Basel

Mirum Pharmaceuticals makes an entrance to Basel

Mirum Pharmaceuticals is the most recent newcomer to the Basel ecosystem. The biotech company launched in San Francisco in 2018 and opened their European office in Basel early in 2019. Mirum focuses on therapies for orphan liver diseases, especially for rare pediatric conditions.

mehr >
13.07.2018

Basel has the biggest economic potential

Basel has the biggest economic potential

Basel has the biggest economic potential in Europe, according to a new study from BAK Economics. The city on the bend of the Rhine ranked particularly well for competitiveness, while Geneva and Zurich also came in the top five.

mehr >

 

(Source: http://www.baselarea.swiss/en/baselarea-swiss/channels/innovation-report.html)